HIV/AIDS

HIV drug market to grow to more than $8 billion by 2013

Published in AIDS Weekly, May 24th, 2004

Decision Resources, Inc., forecast the HIV drug market will grow to more than $8 billion by 2013.

Novel therapeutic classes that augment treatment options for the treatment-experienced population will drive the market.

The new Pharmacor study entitled "Human Immunodeficiency Virus" finds that, despite advances in therapy, the HIV drug market is constrained by social and political pressures on the pharmaceutical industry.

"HIV is a highly politically and socially charged disease; this factor has important implications for drug developers," said Aarti Raja, PhD, analyst, Decision Resources. "Pharmaceutical manufacturers have been...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2004-05-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry